Developer docs
API playgroundTry for free, no card

Search company profiles

Righton

Full company profile

uuid00032f1

Namestring
Righton
Websiteurl
rightongene.com
Company typeenum
Private
Founded yearint
2012
Short descriptiontext

Righton is a Shanghai-based genetic engineering technology company (founded 2012, SSE Star Market: 688217) serving clinical diagnostics and life sciences customers, with KingMed Diagnostics acting as both strategic investor and channel partner.

Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersShanghai, China
HQ citystring
Shanghai
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
genetic engineering services, molecular diagnostics, DNA sequencing services, genomics research, biotechnology products
Industry2 codes
PRIMARYAFABALAJ
Seed Trait Licensing & IP Management (Licensing, freedom-to-operate)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Seed Technologies (Genetic Engineering & Trait Development)
SECONDARYAFAGAIAL
Seed Licensing & IP/Royalty Management
Agriculture & Food Production/Crop Farming/Seed Production & Plant Breeding (Seed Multiplication, Hybrid Seed, Certified Seed)
SIC code1 code
  • Patent Owners & Lessors6794
Product category
Genetic Engineering / Biotechnology
No data
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Righton is a Shanghai-based genetic engineering technology company founded in 2012 that develops and commercializes genetic engineering technology. The company operates with 251-500 employees and trades publicly on the Shanghai Stock Exchange (sse:688217). Specific product lines and service offerings are not detailed in the available source material because the company's website (rightongene.com) was offline (Alibaba Cloud hosting manually stopped) at the time of data collection.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Genetic Engineering Technology
CategoryGenetic Engineering Technology
Description

Genetic engineering technology platform and related services, indicated by the company's description as a genetic engineering technology company. Specific product lines are not enumerated in the available source content.

No data
Peers10 records
TypeBroad incumbent
Description

Global ag-biotech division of Bayer with a major genetic engineering trait portfolio (including legacy Monsanto assets). Comparable as a broad incumbent in the genetic engineering IP and seed trait licensing space.

2Origin Agritech
TypeDirect peer
Description

Beijing-based genetic engineering and seed trait developer with a comparable business model of developing and commercializing GMO corn and other crop traits in China. Directly comparable in technology stack, target customer (Chinese seed companies and farmers), and regulatory exposure.

TypeBroad incumbent
Description

Global seed and crop protection player with a developing genetic engineering trait portfolio. Comparable as a broad incumbent competing in the same genetic engineering value chain and licensing ecosystem.

4Cathay Biotech
TypeEmerging player
Description

Shanghai-headquartered Chinese biotech company focused on bio-based materials and synthetic biology. Comparable as a Chinese public biotech with overlap in advanced biotechnology / genetic engineering capabilities and STAR Market ecosystem.

5Yuan Longping High-tech Agriculture
TypeDirect peer
Description

Major Chinese hybrid seed and crop genetics company, listed on the Shenzhen Stock Exchange. Comparable as a publicly-traded Chinese seed/genetics company with overlap in genetic improvement and trait commercialization for Chinese agriculture.

TypeDirect peer
Description

One of China's largest privately-held ag-biotech companies focused on GMO corn and soybean trait development. Directly comparable as a Chinese genetic engineering and seed IP company targeting the same domestic customer base and regulatory pathway.

TypeRegional player
Description

State-owned Chinese seed conglomerate with significant domestic market share in hybrid seed and crop genetics. Comparable as a domestic Chinese player in seed genetics and as a customer/competitor for genetic engineering trait licensing.

8Winall Hi-tech Seed
TypeRegional player
Description

Anhui-based Chinese seed company focused on hybrid rice, corn, and wheat varieties. Comparable as a domestic Chinese seed company that could be a customer or competitor in the genetic engineering trait licensing ecosystem.

9Corteva Agriscience
TypeBroad incumbent
Description

Global seed and crop protection major with leading genetic engineering trait portfolios. Comparable as a broad incumbent in the genetic engineering and seed licensing space where Righton competes for the same underlying end-market.

TypeBroad incumbent
Description

Global ag-biotech incumbent owned by Sinochem/ChemChina, with a major presence in seeds, crop protection, and genetic traits. Comparable as a dominant competitor in the Chinese and global seed biotech space where Righton operates.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Righton

Genetic Engineering / Biotechnologyrightongene.com

Righton is a Shanghai-based genetic engineering technology company (founded 2012, SSE Star Market: 688217) serving clinical diagnostics and life sciences customers, with KingMed Diagnostics acting as both strategic investor and channel partner.

Righton firmographics

Firmographics
Name
Righton
Website
https://rightongene.com
Company type
Private
Founded year
2012
Headcount range
251–500 employees
Short description
Righton is a Shanghai-based genetic engineering technology company (founded 2012, SSE Star Market: 688217) serving clinical diagnostics and life sciences customers, with KingMed Diagnostics acting as both strategic investor and channel partner.
Ownership category
akta.pro rank

Righton industry classification

Industry
Product category
Genetic Engineering / Biotechnology
SIC
Patent Owners & Lessors (6794)
akta.pro industry
PRIMARYAFABALAJ
Seed Trait Licensing & IP Management (Licensing, freedom-to-operate)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Seed Technologies (Genetic Engineering & Trait Development)
SECONDARYAFAGAIAL
Seed Licensing & IP/Royalty Management
Agriculture & Food Production/Crop Farming/Seed Production & Plant Breeding (Seed Multiplication, Hybrid Seed, Certified Seed)

Keywords

  • Genetic engineering services
  • Molecular diagnostics
  • DNA sequencing services
  • Genomics research
  • Biotechnology products

Where Righton is headquartered

Location

Headquarters

HQ city
Shanghai
HQ country
China
HQ region
Asia

Markets served

Righton business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Righton product offering

Product offering

Core offering

Righton is a Shanghai-based genetic engineering technology company founded in 2012 that develops and commercializes genetic engineering technology. The company operates with 251-500 employees and trades publicly on the Shanghai Stock Exchange (sse:688217). Specific product lines and service offerings are not detailed in the available source material because the company's website (rightongene.com) was offline (Alibaba Cloud hosting manually stopped) at the time of data collection.

Differentiator

Problem solved

Functional benefit

Products and services

  • Genetic Engineering Technology Genetic engineering technology platform and related services, indicated by the company's description as a genetic engineering technology company. Specific product lines are not enumerated in the available source content.

Companies that use Righton

Customer profile

Ideal customer profiles1 record

Righton technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Righton competitors and assessment

Company assessment

Broad incumbents

  • Bayer Crop Science: Global ag-biotech division of Bayer with a major genetic engineering trait portfolio (including legacy Monsanto assets). Comparable as a broad incumbent in the genetic engineering IP and seed trait licensing space.
  • BASF Agricultural Solutions: Global seed and crop protection player with a developing genetic engineering trait portfolio. Comparable as a broad incumbent competing in the same genetic engineering value chain and licensing ecosystem.
  • Corteva Agriscience: Global seed and crop protection major with leading genetic engineering trait portfolios. Comparable as a broad incumbent in the genetic engineering and seed licensing space where Righton competes for the same underlying end-market.
  • Syngenta Group: Global ag-biotech incumbent owned by Sinochem/ChemChina, with a major presence in seeds, crop protection, and genetic traits. Comparable as a dominant competitor in the Chinese and global seed biotech space where Righton operates.

Direct peers

  • Origin Agritech: Beijing-based genetic engineering and seed trait developer with a comparable business model of developing and commercializing GMO corn and other crop traits in China. Directly comparable in technology stack, target customer (Chinese seed companies and farmers), and regulatory exposure.
  • Yuan Longping High-tech Agriculture: Major Chinese hybrid seed and crop genetics company, listed on the Shenzhen Stock Exchange. Comparable as a publicly-traded Chinese seed/genetics company with overlap in genetic improvement and trait commercialization for Chinese agriculture.
  • Beijing Dabeinong Technology (DBN): One of China's largest privately-held ag-biotech companies focused on GMO corn and soybean trait development. Directly comparable as a Chinese genetic engineering and seed IP company targeting the same domestic customer base and regulatory pathway.

Emerging players

  • Cathay Biotech: Shanghai-headquartered Chinese biotech company focused on bio-based materials and synthetic biology. Comparable as a Chinese public biotech with overlap in advanced biotechnology / genetic engineering capabilities and STAR Market ecosystem.

Regional players

  • China National Seed Group: State-owned Chinese seed conglomerate with significant domestic market share in hybrid seed and crop genetics. Comparable as a domestic Chinese player in seed genetics and as a customer/competitor for genetic engineering trait licensing.
  • Winall Hi-tech Seed: Anhui-based Chinese seed company focused on hybrid rice, corn, and wheat varieties. Comparable as a domestic Chinese seed company that could be a customer or competitor in the genetic engineering trait licensing ecosystem.

Market position

Customer concentration

Righton financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Righton leadership team

Management profile

Number of profiles

Righton funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Righton M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Righton

What does Righton do?

Righton is a Shanghai-based genetic engineering technology company founded in 2012 that develops and commercializes genetic engineering technology. The company operates with 251-500 employees and trades publicly on the Shanghai Stock Exchange (sse:688217). Specific product lines and service offerings are not detailed in the available source material because the company's website (rightongene.com) was offline (Alibaba Cloud hosting manually stopped) at the time of data collection.

When was Righton founded?

Righton was founded in 2012. It employs 251 to 500 people.

Where is Righton based?

Righton is headquartered in Shanghai, China, in the Asia region.

Who are Righton's main competitors?

Broad incumbents on record are Bayer Crop Science, BASF Agricultural Solutions, Corteva Agriscience and Syngenta Group. Direct peers are Origin Agritech, Yuan Longping High-tech Agriculture and Beijing Dabeinong Technology (DBN). Cathay Biotech is listed as an emerging player. Regional players are China National Seed Group and Winall Hi-tech Seed.

Does Righton have an API?

No public API is recorded for Righton.

What industry is Righton in?

Righton's product category is Genetic Engineering / Biotechnology. Its primary akta.pro industry code is AFABALAJ, Seed Trait Licensing & IP Management (Licensing, freedom-to-operate), with a secondary code of AFAGAIAL, Seed Licensing & IP/Royalty Management. Its SIC code is 6794.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals